To explore the importance of the MR/FGF21 axis in a more clinically relevant setting, we investigated whether spironolactone, an MR antagonist commonly used to treat HF (29, 30), worked through FGF21 to exert its cardioprotective effects. This evidence concerns the gene FGF21 and hydrops fetalis.